Literature DB >> 11308142

Surgical treatment of lung cancer invading the chest wall: results and prognostic factors.

P Magdeleinat1, M Alifano, C Benbrahem, L Spaggiari, C Porrello, P Puyo, P Levasseur, J F Regnard.   

Abstract

BACKGROUND: The study was performed to assess prognostic factors in patients with lung cancer invading the chest wall treated by surgery.
METHODS: We reviewed retrospectively clinical records of all patients operated on for lung cancer invading chest wall structures between 1984 and 1998.
RESULTS: Two hundred one patients were operated on in this 14-year period. One hundred thirty-seven lobectomies, 55 pneumonectomies, and 9 wedge resections were performed. Extrapleural resection (when invasion was limited to the parietal pleura) and chest wall resection (in the case of invasion of deeper structures) were combined with pulmonary resection in 79 (39%) and 122 (61%) cases, respectively. Pathologic TNM stages were T3N0 in 116 (57.5%) cases, T3N1 in 52 (26%), T3N2 in 27 (13.5%), and T4N0-N1 in 6 (3%). A complete resection was achieved in 167 (83%) cases. Fourteen postoperative deaths (7%) occurred. One hundred thirty-nine patients (74%) underwent postoperative radiotherapy. Actuarial 5-year survival was 24% and 13% after complete and incomplete resection, respectively (p < 0.05). Actuarial 5-year survival after complete resection was 25% in T3N0 patients, 20% in T3N1, and 21% in T3N2. In completely resected patients, univariate and multivariate analyses identified three independent prognostic factors: nodal involvement, depth of parietal invasion, and age. Radiation therapy did not improve survival if a complete resection was possible.
CONCLUSIONS: Completeness of resection, nodal involvement, depth of invasion, and age affect survival of patients with lung cancer invading the chest wall. N2 disease should not be considered a contraindication to surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11308142     DOI: 10.1016/s0003-4975(00)02666-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  22 in total

1.  Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection.

Authors:  Nicole M Geissen; Robert Medairos; Edgar Davila; Sanjib Basu; William H Warren; Gary W Chmielewski; Michael J Liptay; Andrew T Arndt; Christopher W Seder
Journal:  Lung       Date:  2016-04-23       Impact factor: 2.584

2.  Predictors of postoperative survival in patients with locally advanced non-small cell lung carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yasumitsu Moriya; Shigetoshi Yoshida; Makoto Suzuki; Kiyoshi Shibuya; Ichiro Yoshino
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

3.  Results of chest wall resection and reconstruction in 162 patients with benign and malignant chest wall disease.

Authors:  Manoucheher Aghajanzadeh; Ali Alavy; Mehrdad Taskindost; Zahra Pourrasouly; Gilda Aghajanzadeh; Sara Massahnia
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

4.  Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion.

Authors:  Takeshi Hanagiri; Shinji Shinohara; Masaru Takenaka; Hidehiko Shimokawa; Yoshika Nagata; Makoto Nakagawa; Hidetaka Uramoto; Tomoko So; Fumihiro Tanaka
Journal:  Indian J Surg       Date:  2012-07-28       Impact factor: 0.656

5.  Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis.

Authors:  Yukitoshi Satoh; Yuichi Ishikawa; Kentaro Inamura; Sakae Okumura; Ken Nakagawa; Eiju Tsuchiya
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

6.  Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach.

Authors:  Mauro Loi; Antonio Mazzella; Isacco Desideri; Ludovic Fournel; Emelyne Canny Hamelin; Philippe Icard; Antonio Bobbio; Marco Alifano
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

7.  Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.

Authors:  Usman Ahmad; Traves D Crabtree; Aalok P Patel; Daniel Morgensztern; Cliff G Robinson; A Sasha Krupnick; Daniel Kreisel; David R Jones; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2017-04-19       Impact factor: 4.330

Review 8.  Primary lung tumors invading the chest wall.

Authors:  Pier Luigi Filosso; Alberto Sandri; Francesco Guerrera; Paolo Solidoro; Giulia Bora; Paraskevas Lyberis; Enrico Ruffini; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 9.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

Review 10.  Surgical management of locally advanced lung cancer.

Authors:  Kohei Yokoi; Tetsuo Taniguchi; Noriyasu Usami; Koji Kawaguchi; Takayuki Fukui; Futoshi Ishiguro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.